Home >> Tag Archives: Veracyte—

Tag Archives: Veracyte—

Veracyte begins EAP for Envisia classifier

May 21, 2018—Veracyte has launched an early access program to begin making its Envisia Genomic Classifier available to patients who are being evaluated for interstitial lung diseases, including idiopathic pulmonary fibrosis. Physicians from Jefferson University, Keck Medicine of USC, Providence Sacred Heart Medical Center (Wash.), and University of California, Los Angeles, are among the first participants to offer the test ...

Read More »

Veracyte, Quest agreement, 5/17

May 2017—Veracyte will extend access to its Afirma Gene Expression Classifier through an agreement with Quest Diagnostics. The agreement is intended to meet growing physician demand for innovative genomic testing services to improve thyroid cancer diagnosis.

Read More »